NVO
NVO
Novo Nordisk A/S
💱 Reports in DKK
$46.19
-$0.89 (-1.89%)
Mkt Cap: $205.26B
Home / NVO / Financial Statements

Novo Nordisk A/S (NVO) Financial Statements

💱 All figures reported in DKK (kr)

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
kr309.06B
kr309.06B ↑6.4%
kr290.40B ↑25.0%
kr232.26B ↑31.3%
kr176.95B ↑25.7%
kr140.80B
Cost of Revenue
kr58.79B
kr58.79B ↑32.0%
kr44.52B ↑24.5%
kr35.77B ↑25.7%
kr28.45B ↑20.2%
kr23.66B
Gross Profit
kr250.28B
kr250.28B ↑1.8%
kr245.88B ↑25.1%
kr196.50B ↑32.3%
kr148.51B ↑26.8%
kr117.14B
R&D Expenses
kr52.04B
kr52.04B ↑8.3%
kr48.06B ↑48.1%
kr32.44B ↑34.9%
kr24.05B ↑35.3%
kr17.77B
SG&A Expenses
kr70.28B
kr70.28B ↑4.3%
kr67.38B ↑9.4%
kr61.60B ↑21.5%
kr50.68B ↑23.4%
kr41.06B
Operating Income
kr127.66B
kr127.66B ↓0.5%
kr128.34B ↑25.1%
kr102.57B ↑37.1%
kr74.81B ↑27.6%
kr58.64B
Interest Expense
kr10.14B
kr4.21B ↑156.5%
kr1.64B ↑202.6%
kr542.00M ↑43.4%
kr378.00M ↑30.8%
kr289.00M
Income Tax
kr28.11B
kr28.11B ↑7.3%
kr26.20B ↑24.8%
kr20.99B ↑55.1%
kr13.54B ↑19.6%
kr11.32B
Net Income
kr102.43B
kr102.43B ↑1.4%
kr100.99B ↑20.7%
kr83.68B ↑50.7%
kr55.52B ↑16.3%
kr47.76B
EBITDA
kr158.38B
kr156.73B ↑5.9%
kr147.94B ↑29.1%
kr114.63B ↑49.3%
kr76.80B ↑17.4%
kr65.39B
EPS
23.03
23.03 ↑1.8%
22.63 ↑21.5%
18.62 ↑52.4%
12.22 ↑17.8%
10.37
Shares Out (Diluted)
17.79B
4.45B ↓0.3%
4.46B ↓0.7%
4.49B ↓1.1%
4.54B ↓1.3%
4.61B